Conference Reports for NATAP
EASL 47th Annual Meeting
April 18th - 22nd 2012
Barcelona, Spain
Back
 
GS-7977 + PEG/RBV in HCV Genotype 1: The ATOMIC Trial An End To Response-Guided Therapy
Reported by Jules Levin